Yiling Pharmaceutical 1.1 Innovative Chinese Medicine Jieyu Capsule Capsule National Listing National Sales Conference was held

On June 30, 2022, hosted by the Psychiatric Basic and Clinical Branch of the Chinese Society of neuroscience (CSNP), Xiangya Second Hospital of Central South University, the Mental Health Center of the Shanghai Jiaotong University School of Medicine, and the first affiliated hospital of Xi'an Jiaotong University The 19th National Academic Annual Conference of the Chinese Academy of Neurosciences and the 19th National Academic Annual Conference was held in Xi'an, Millennium Capital. At the meeting, "relieve worry and remove annoyance, born of the sun" -The innovative drugs in the spiritual field are grandly held.

The National Listing Association invited the chairman of the Psychiatric Branch of the Chinese Medical Association, Professor Li Lingjiang, honorary chairman of CSNP, Vice Chairman of the Psychiatric Branch of the Chinese Medical Association, Professor Wang Xiaoping, CSNP chairman, executive member of the Psychiatry Branch of the Chinese Medical Association, and Xi'an Transportation Professor Ma Xiancang, deputy dean of the First Affiliated Hospital of the University, Professor Xu Xiufeng, Executive Member of the Chinese Medical Association Psychiatric Branch, Professor Xu Xiufeng, First Affiliated Hospital of Kunming Medical University, Deputy Chairman of CSNP, Professor Li Tao Professor Xu Lin and other well -known experts and scholars in the industry and experts from the country from the country attended the meeting to witness. Professor Li Lingjiang was chaired by the meeting.

Professor Li Lingjiang pointed out in his speech that depression disorders have become diseases that cannot be ignored and have a serious impact on people's physical and mental health, and the incidence of depression has increased year by year. The characteristics of the consultation rate have increasingly attracted the attention of the public. As a leading company in China, Ling Pharmaceuticals has good results in the fields of cardiovascular, breathing, endocrine, tumors and other fields. The listing of the national 1.1 -type innovative Chinese medicine relief capsules also means that Yiling Pharmaceutical officially enters the spiritual field of Ling Pharmaceutical. He hopes and expects to relieve depression capsules to bring the gospel to patients with depression and contribute to the public's health.

Ji Lingshuang, manager of the new product market department of Ling Pharmaceutical, delivered a speech on behalf of Yiling Pharmaceutical. He said that since its establishment in 1992, Eling Pharmaceutical has been committed to scientific and technological innovation and benefiting the people. In the past three decades, the enterprise has independently developed a number of innovative patent Chinese medicines such as Tongxinluo Capsule, Lianhua Qing Plague Capsules, Ginseng Yangxin Capsules, and Qixin Qiangxin Capsules, and won six national science and technology awards. Essence Xieyu Different Capsule is the thirteenth innovative patent traditional Chinese medicine listed by Ling Pharmaceutical. The system summarizes the clinical experience of Zhongjing Jingfang. Patients with mild depression, especially patients with depression and anxiety, have comprehensive intervention advantages, which can improve depression. Anxiety and mental disorder can relieve physical sensory disorders and bring new hope to patients with depression. He also said that in the future, Ling Pharmaceutical will continue to accelerate the exploration of clinical evidence, carry forward the characteristics of traditional Chinese medicine, and benefit the majority of patients.

At the National Launch Conference, experts such as Professor Li Lingjiang, Professor Wang Xiaoping, and Professor Ma Xiancang jointly launched the "relief of worries and annoyance, born in the sun -the new product listing meeting" drawing axis, and announced that the relief capsule was officially launched.

News link:

In December 2021, Yiling Pharmaceutical issued an announcement saying that received the "Drug Registration Certificate" issued by the State Drug Administration approved and approved the listing of relief capsules for its production. intellectual property.

The 1.1 type 1.1 patent innovation Chinese medicine independently developed by Xieyu Capsule Capsule is also its first innovative drug in the spiritual field. Yiling Pharmaceutical carried out clinical trials of multi-center, random, double-blind dual simulation, placebo and fluinotine hydrochloride tablets in parallel. The basis of the baseline, the test group is better than the placebo group, and is not inferior to the fluoricate tablet group.

As of now, Yiling Pharmaceutical has 13 patented Chinese medicines, covering cardiovascular and cerebrovascular diseases, respiratory diseases, tumors, diabetes, and nervous system diseases, forming unique product layout advantages.

- END -